Last reviewed · How we verify
Sodium Chloride 0.9%, Intravenous
Sodium Chloride 0.9%, Intravenous is a Small molecule drug developed by Kathirvel Subramaniam. It is currently FDA-approved. Also known as: Saline.
At a glance
| Generic name | Sodium Chloride 0.9%, Intravenous |
|---|---|
| Also known as | Saline |
| Sponsor | Kathirvel Subramaniam |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) (PHASE2, PHASE3)
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies (PHASE1)
- MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) (PHASE3)
- Sphenopalatine Ganglion Block for Post-Dural Puncture Headache: A Pilot Randomised Controlled Trial (NA)
- Tocilizumab in Lung Transplantation (PHASE2)
- Improving Preterm Kidney Outcomes With Caffeine (PHASE2)
- Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial (PHASE3)
- Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sodium Chloride 0.9%, Intravenous CI brief — competitive landscape report
- Sodium Chloride 0.9%, Intravenous updates RSS · CI watch RSS
- Kathirvel Subramaniam portfolio CI
Frequently asked questions about Sodium Chloride 0.9%, Intravenous
What is Sodium Chloride 0.9%, Intravenous?
Sodium Chloride 0.9%, Intravenous is a Small molecule drug developed by Kathirvel Subramaniam.
Who makes Sodium Chloride 0.9%, Intravenous?
Sodium Chloride 0.9%, Intravenous is developed and marketed by Kathirvel Subramaniam (see full Kathirvel Subramaniam pipeline at /company/kathirvel-subramaniam).
Is Sodium Chloride 0.9%, Intravenous also known as anything else?
Sodium Chloride 0.9%, Intravenous is also known as Saline.
What development phase is Sodium Chloride 0.9%, Intravenous in?
Sodium Chloride 0.9%, Intravenous is FDA-approved (marketed).
Related
- Manufacturer: Kathirvel Subramaniam — full pipeline
- Also known as: Saline
- Compare: Sodium Chloride 0.9%, Intravenous vs similar drugs
- Pricing: Sodium Chloride 0.9%, Intravenous cost, discount & access